Hostname: page-component-5db58dd55d-f6s65 Total loading time: 0 Render date: 2026-05-28T01:15:29.553Z Has data issue: false hasContentIssue false
  • English
  • Français

Soya isoflavones suppress phorbol 12-myristate 13-acetate-induced COX-2 expression in MCF-7 cells

Published online by Cambridge University Press:  08 March 2007

Tak Yi Lau  and
Lai K. Leung
Tak Yi Lau
Affiliation:
Department of Biochemistry, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong
Lai K. Leung*
Affiliation:
Food and Nutritional Sciences Programme, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong Department of Biochemistry, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong
*
*Corresponding author: Dr Lai K. Leung, fax +852 26037732, email laikleung@yahoo.com
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the 'Save PDF' action button.

Epidemiological studies indicate that Asian women have a lower incidence of breast cancer compared with their counterparts in the West, and soya consumption has been suggested as a contributory factor. Clinical and animal studies have revealed that cyclooxygenase-2 (COX-2) expression is associated with a risk of breast cancer. In the present study, we investigated the effect of soya isoflavones on the expression of COX-2 in the breast cell line MCF-7. Genistein, daidzein and equol were found to inhibit COX-2 expression induced by phorbol 12-myristate 13-acetate (PMA). Similar findings were observed in the COX-2 protein analysis. In order to study transcriptional control, a fragment of the 5′-flanking region of the hCOX-2 gene was amplified and inserted into a firefly luciferase reporter plasmid. The reporter assay indicated that the transactivation of the hCOX-2 promoter was induced by PMA, and activity was inhibited with the co-administration of genistein, daidzein or equol. An activator protein-1 (AP-1)/cyclic AMP response element binding protein (CREB) binding site (−59/−53) was identified in hCOX-2 promoter, and this could be critical in PMA-induced COX-2 expression. Truncation reporter plasmids with (−70/−36) and without (−51/−36) AP-1/CREB were constructed for subsequent analysis. The results revealed that the hCOX-2 promoter transactivation suppressed by isoflavone could be dependent on AP-1/CREB binding. Nonetheless, this study illustrated that the soya isoflavones reduced COX-2 expression, which could be important in the post-initiation events of breast carcinogenesis.

Keywords

GenisteinDaidzeinEquolCOX-2Breast cancer cells

Information

Type
Research Article
Information
British Journal of Nutrition , Volume 96 , Issue 1 , January 2006 , pp. 169 - 176
Copyright
Copyright © The Nutrition Society 2006

References

Allred, CD, Allred, KF, Ju, YH, Clausen, LM, Doerge, DR, Schantz, SL, Korol, DL, Wallig, MA & Helferich, WGDietary genistein results in larger MNU-induced, estrogen-dependent mammary tumours following ovariectomy of Sprague-Dawley rats. Carcinogenesis (2004) 25, 211–218.CrossRefGoogle ScholarPubMed
Altundag, K, Altunday, O, Gunduz, M & Arun, BPossible interaction between activator protein-1 and proto-oncogene B-cell lymphoma gene 6 in breast cancer patients resistant to tamoxifen. Med Hypotheses (2004) 63, 823–826.CrossRefGoogle ScholarPubMed
Arun, B, Zhang, H, Mirza, NQ, Hortobogyi, GN, Hung, MC & Meric, FGrowth inhibition of breast cancer cells by celecoxib. Breast Cancer Res Treat (2001) 69, 234(abstract).Google Scholar
Dong, Z, Birrer, MJ, Watts, RG, Matrisian, LM & Colburn, NHBlocking of tumour promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc Natl Acad Sci USA (1994) 91, 609–613.CrossRefGoogle ScholarPubMed
Greenwald, PClinical trials in cancer prevention: current results and perspectives for the future. J Nutr (2004) 134, 3507S–3512S.CrossRefGoogle ScholarPubMed
Gupta, RA & DuBois, RNColorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer (2001) 1, 11–21.CrossRefGoogle ScholarPubMed
Harris, RE, Alshafie, GA, Abou-Issa, H & Seibert, KChemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Res (2000) 60, 2101–2103.Google ScholarPubMed
Howe, LR, Subbaramaiah, K, Brown, AMC & Dannenberg, AJCyclooxygenase-2: A target for the prevention and treatment of breast cancer. Endocr Relat Cancer (2001) 8, 97–114.CrossRefGoogle ScholarPubMed
Howe, LR, Subbaramaiah, K, Patel, J et al. . Celecoxib, a selective cyclooxygenase-2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. Cancer Res (2002) 62, 5405–5407.Google ScholarPubMed
Izumi, T, Piskula, MK, Osawa, S, Obata, A, Tobe, K, Saito, M, Kataoka, S, Kubota, Y & Kikuchi, MSoy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans. J Nutr (2000) 130, 1695–1699.CrossRefGoogle ScholarPubMed
Kosaka, T, Miyata, A, Ihara, H, Hara, S, Sugimoto, T, Takeda, O, Takahashi, E & Tanabe, TCharacterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2. Eur J Biochem (1994) 221, 889–897.CrossRefGoogle ScholarPubMed
Kundu, JK, Na, H-K, Chun, K-S, Kim, Y-K, Lee, SJ, Lee, SS, Lee, O-S, Sim, Y-C & Surh, Y-JInhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells. J Nutr (2003) 133, 3805S–3810S.CrossRefGoogle ScholarPubMed
Leung, LK & Wang, TTBcl-2 is not reduced in the death of MCF-7 cells at low genistein concentration. J Nutr (2000) 130, 2922–2926.CrossRefGoogle Scholar
Livak, KJ & Schmittgen, TDAnalysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 25, 402–408.CrossRefGoogle ScholarPubMed
Miller, C, Zhang, M, He, Y, Zhao, J, Pelletier, J-P, Martel-Pelletier, J & Di Battista, JATranscriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins. J Cell Biochem (1998) 69, 392–413.3.0.CO;2-I>CrossRefGoogle ScholarPubMed
Morton, MS, Arisaka, O, Miyake, N, Morgan, LD & Evans, BAPhytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr (2002) 132, 3168–3171.CrossRefGoogle ScholarPubMed
Murata, M, Midorikawa, K, Koh, M, Umezawa, K & Kawanishi, SGenistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs. Biochemistry (2004) 43, 2569–2577.CrossRefGoogle ScholarPubMed
Mutoh, M, Takahashi, M, Fukuda, K, Matsushima-Hibiya, Y, Mutoh, H, Sugimura, T & Wakabayshi, K. Carcinogenesis (2000) 21, 959–963.CrossRefGoogle Scholar
Nakatsugi, S, Hhta, T, Kawamori, T, Mutoh, M, Tanigawa, T, Watanabe, K, Sugie, S, Sugimura, T & Wakabayahi, KChemoprevention by nimesulide, a selective cyclooxygenase-2 inhibitor, of 2-amino-1-methyl-6-phenylimidazol [4,5-b]pyridine (PhIP)- induced mammary gland carcinogenesis in rats. Japan J Cancer Res (2000) 91, 886–892.CrossRefGoogle Scholar
Po, LS, Wang, TT, Chen, ZY & Leung, LKGenistein-induced apoptosis in MCF-7 cells involves changes in Bak and Bcl-x without evidence of anti-oestrogenic effects. Br J Nutr (2002) 88, 463–469.CrossRefGoogle Scholar
Prosperi, JR, Mallery, SR, Kigerl, KA, Erfurt, AA & Robertson, FMInvasive and angiogenic phenotype of MCF-7 human breast tumour cells expressing human cyclooxygenase-2. Prostaglandins Other Lipid Mediat (2004) 73, 249–264.CrossRefGoogle ScholarPubMed
Richard, N, Porath, D, Radspieler, A & Schwager, JEffects of resveratrol, piceatannol, tri-acetoxystilbene, and genistein on the inflammatory response of human peripheral blood leukocytes. Mol Nutr Food Res (2005) 49, 431–442.CrossRefGoogle ScholarPubMed
Simstein, R, Burow, M, Parker, A, Weldon, C & Beckman, BApoptosis, chemoresistance, and breast cancer: insights from the MCF-7 cell model system. Exp Biol Med (Maywood) (2003) 228, 995–1003.CrossRefGoogle ScholarPubMed
Singh, B & Lucci, ARole of cyclooxygenase-2 in breast cancer. J Surg Res (2002) 108, 173–179.CrossRefGoogle ScholarPubMed
Soslow, R, Dannenberg, A, Rush, D, Woerner, BM, Khan, KN, Masferrer, J & Koki, ACOX-2 is expressed in human pulmonary, colonic, and mammary tumours. Cancer (2000) 89, 2637–2645.3.0.CO;2-B>CrossRefGoogle Scholar
Subbaramaiah, K, Chung, WJ, Michaluart, P, Telang, N, Tanabe, T, Inoue, H, Jang, M, Pezzuto, JM & Dannenberg, AJResveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem (1998) 273, 21875–21882.CrossRefGoogle ScholarPubMed
Subbaramaiah, K, Cole, PA & Dannenberg, AJRetinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and independent mechanisms. Cancer Res (2002a) 62, 2522–2530.Google ScholarPubMed
Subbaramaiah, K, Norton, L, Gerald, W & Dannenberg, AJCyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer - evidence for involvement of AP-1 and PEA3. J Biol Chem (2002b) 277, 18649–18657.CrossRefGoogle ScholarPubMed
Sun, Y, Wenger, L, Brinckerhoff, CE, Misra, RR & Cheung, HSBasic calcium phosphate crystals induce matrix metalloproteinase-1 through the Ras/mitogen-activated protein kinase/c-fos/AP-1/ metalloproteinase 1 pathway. J Biol Chem (2002) 277, 1544–1552.CrossRefGoogle ScholarPubMed
Takahashi, Y, Kawahara, F, Noguchi, M, Miwa, K, Sato, H, Seiki, M, Inoue, H, Tanabe, T & Yoshimoto, TActivation of matrix metalloproteinase-2 in human breast cancer cells over-expressing cyclooxygenase-1 or -2. FEBS Letts (1999) 460, 145–148.CrossRefGoogle ScholarPubMed
Trifan, OC & Hla, TCyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. J Cell Mol Med (2003) 7, 207–222.CrossRefGoogle ScholarPubMed
Upadhyaya, P & El Bayoumy, KEffect of dietary soy protein isolate, genistein, and 1,4-phenylenebis(methylene)selenocyanate on DNA binding of 7,12-dimethyl-benz[a]anthracene in mammary glands of CD rats. Oncol Rep (1998) 5, 1541–1545.Google Scholar
Zhang, F, Altorki, NK, Mestre, JR, Subbaramaiah, K & Dannenberg, AJCurcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis (1999) 20, 445–451.CrossRefGoogle ScholarPubMed
Zhang, Y, Hendrich, S & Murphy, PAGlucuronides are the main isoflavone metabolites in women. J Nutr (2003) 133, 399–404.CrossRefGoogle ScholarPubMed
Ziegler, RG, Hoover, RN, Pike, MC, Hidesheim, A, Nomura, AM, West, DW, Wu-Williams, AAH, Kolonel, LN, Horn-Ross, PL & Rosenthal, JFMigration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst (1993) 85, 1819–1827.CrossRefGoogle ScholarPubMed